Firefly Neuroscience (NASDAQ:AIFF) Issues Earnings Results

Firefly Neuroscience (NASDAQ:AIFF) issued its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per share (EPS) for the quarter, FiscalAI reports. The firm had revenue of $0.49 million for the quarter. Firefly Neuroscience had a negative net margin of 1,740.98% and a negative return on equity of 229.99%.

Firefly Neuroscience Stock Down 1.9%

Shares of NASDAQ AIFF traded down $0.04 during mid-day trading on Thursday, hitting $1.77. 396,370 shares of the company traded hands, compared to its average volume of 7,123,227. Firefly Neuroscience has a 1 year low of $0.62 and a 1 year high of $3.77. The stock has a market capitalization of $26.10 million, a price-to-earnings ratio of -0.98 and a beta of 0.60. The business has a 50 day moving average of $1.93 and a two-hundred day moving average of $1.48.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AIFF. Weiss Ratings lowered Firefly Neuroscience from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, May 4th. Wall Street Zen lowered Firefly Neuroscience from a “hold” rating to a “sell” rating in a research note on Saturday, May 2nd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.

Institutional Investors Weigh In On Firefly Neuroscience

Several hedge funds have recently modified their holdings of the stock. Jane Street Group LLC purchased a new stake in shares of Firefly Neuroscience during the fourth quarter valued at $53,000. Vanguard Group Inc. boosted its position in shares of Firefly Neuroscience by 393.3% in the third quarter. Vanguard Group Inc. now owns 503,071 shares of the company’s stock worth $1,464,000 after buying an additional 401,085 shares during the period. Savvy Advisors Inc. acquired a new stake in shares of Firefly Neuroscience in the third quarter worth $63,000. Finally, Geode Capital Management LLC grew its holdings in shares of Firefly Neuroscience by 92.9% during the second quarter. Geode Capital Management LLC now owns 120,604 shares of the company’s stock valued at $341,000 after buying an additional 58,067 shares in the last quarter. 4.96% of the stock is owned by hedge funds and other institutional investors.

About Firefly Neuroscience

Firefly Neuroscience is a clinical‐stage neurotechnology company focused on developing digital biomarkers and cognitive assessment tools for the early detection and monitoring of neurological disorders. The company’s platform combines mobile applications, sensor technology and advanced analytics to capture objective brain function data outside of traditional clinical settings. By providing real‐world cognitive and physiological measurements, Firefly aims to improve diagnosis, track disease progression and support therapeutic development.

The company’s flagship offering is a smartphone‐based cognitive assessment app that guides users through a series of interactive tasks designed to measure attention, memory, processing speed and executive function.